|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/50 | (2006.01) |
| (11) | Number of the document | 2801355 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14172398.1 |
| Date of filing the European patent application | 2005-10-07 | |
| (97) | Date of publication of the European application | 2014-11-12 |
| (45) | Date of publication and mention of the grant of the patent | 2015-05-20 |
| (46) | Date of publication of the claims translation | 2015-09-25 |
| (30) | Number | Date | Country code |
| 200401546 | 2004-10-08 | DK | |
| 200401736 | 2004-11-10 | DK | |
| 200500211 | 2005-02-11 | DK | |
| 200500419 | 2005-03-23 | DK | |
| 691513 P | 2005-06-16 | US |
| (72) |
Nilsson, Henrik, DK
Schönharting, Florian, DK
Müller, Bernd, W., DE
Robinson, Joseph, R., US
|
| (73) |
FWP IP APS,
Østergade 24A, 1100 København,
DK
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kontroliuojamos atpalaidavimo farmacinės kompozicijos, apimančios fumaro rūgšties esterį |
| Controlled release pharmaceutical compositions comprising a fumaric acid ester |
| Payment date | Validity (years) | Amount | |
| 2020-09-25 | 16 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2021-09-06 |